Biktarvy, formally known as biktarvy, is a powerful single-tablet regimen for controlling HIV infection. This drug unites three essential antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the the viral ability to multiply within the body, significantly lowering the viral burden. For many individuals,